Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.32 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 2/20 | 0.32 |
| ▸ | PEPD | P12955 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1914171 | 1.00 | ATM (0.34) | ATMPLA2G1BATG4BCTSKPEPD | |
| SCHEMBL26980895 | 0.80 | ATM (0.52) | ATMPLA2G1BATG4BCTSKPEPD | |
| SCHEMBL26980896 | 0.80 | ATM (0.52) | ATMPLA2G1BATG4BCTSKPEPD | |
| SCHEMBL26118721 | 0.80 | ATM (0.52) | ATMPLA2G1BATG4BCTSKPEPD | |
| SCHEMBL6126706 | 0.80 | ATM (0.52) | ATMPLA2G1BATG4BCTSKPEPD | |
| SCHEMBL5087041 | 0.80 | ATM (0.52) | ATMPLA2G1BATG4BCTSKPEPD | |
| SCHEMBL609347 | 0.80 | NR1H2 (0.32) | ATM | |
| SCHEMBL609611 | 0.80 | NR1H2 (0.32) | ATM | |
| SCHEMBL28109587 | 0.77 | PEPD (0.37) | ATMPEPD | |
| SCHEMBL7744767 | 0.76 | GAA (0.32) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011119853-A1 | ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011079327-A1 | ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-06-30 | — | — | WO | disclosed |